The adenovirus (Ad) penton base protein facilitates viral infection by binding cell surface integrins, triggering receptormediated endocytosis and mediating endosomal penetration. Given these multiple functions, recombinant penton base proteins have been utilized as non-viral vehicles for gene transfer by our lab and others. Although we have previously demonstrated that penton base-derived vectors undergo integrin-specific binding and cell entry, less than desirable levels of gene expression have led us to re-evaluate the recombinant penton base as an agent for gene delivery. To do so, we have examined here the intracellular trafficking of an Ad serotype 5 (Ad5) recombinant penton base protein (PB). Here, we not only observed that PB utilizes a similar, typical trafficking pathway of whole Ad, but also found that PB entered HeLa cells through pathways not yet identified as contributing to cell entry by the whole virus. We show by high-resolution confocal microscopy and biochemical methods that binding to a v -integrins is a requirement for cell entry, but that early internalization stages did not substantially pass through clathrin-positive and early endosomal compartments. Moreover, a subpopulation of internalized protein localized with caveolin-positive compartments and Golgi markers, suggesting that a certain percentage of proteins pass through nonclathrin-mediated pathways. Similar to the virus, trafficking toward the nucleus was affected by disruption of microtubules and dynein. The majority of penton base molecules avoided the lysosome while facilitating early vesicle release of low molecular weight dextran molecules. In further support of a vesicle escape capacity, a subpopulation of internalized penton base appeared to enter the nucleus, as observed by high-resolution confocal microscopy and cell fractionation. As a confirmation of these findings, we demonstrate that a recombinant penton base facilitated cytosolic entry of an siRNA molecule as observed by RNA interference of a marker gene. Based on our findings here, we suggest that whereas soluble penton base proteins may enter cells through clathrinand non-clathrin-mediated pathways, vesicle escape and nuclear delivery appear to be supported by a clathrin-mediated pathway. As our previous efforts have focused on utilizing recombinant penton base proteins as delivery agents for therapeutics, these findings allow us to evaluate the use of the penton base as a cell entry and intracellular trafficking agent, and may be of interest concerning the development of vectors for efficient delivery of therapeutics to cells. Gene Therapy (2006) 13, 821-836.
The adenovirus (Ad) penton base protein facilitates viral infection by binding cell surface integrins, triggering receptormediated endocytosis and mediating endosomal penetration. Given these multiple functions, recombinant penton base proteins have been utilized as non-viral vehicles for gene transfer by our lab and others. Although we have previously demonstrated that penton base-derived vectors undergo integrin-specific binding and cell entry, less than desirable levels of gene expression have led us to re-evaluate the recombinant penton base as an agent for gene delivery. To do so, we have examined here the intracellular trafficking of an Ad serotype 5 (Ad5) recombinant penton base protein (PB). Here, we not only observed that PB utilizes a similar, typical trafficking pathway of whole Ad, but also found that PB entered HeLa cells through pathways not yet identified as contributing to cell entry by the whole virus. We show by high-resolution confocal microscopy and biochemical methods that binding to a v -integrins is a requirement for cell entry, but that early internalization stages did not substantially pass through clathrin-positive and early endosomal compartments. Moreover, a subpopulation of internalized protein localized with caveolin-positive compartments and Golgi markers, suggesting that a certain percentage of proteins pass through nonclathrin-mediated pathways. Similar to the virus, trafficking toward the nucleus was affected by disruption of microtubules and dynein. The majority of penton base molecules avoided the lysosome while facilitating early vesicle release of low molecular weight dextran molecules. In further support of a vesicle escape capacity, a subpopulation of internalized penton base appeared to enter the nucleus, as observed by high-resolution confocal microscopy and cell fractionation. As a confirmation of these findings, we demonstrate that a recombinant penton base facilitated cytosolic entry of an siRNA molecule as observed by RNA interference of a marker gene. Based on our findings here, we suggest that whereas soluble penton base proteins may enter cells through clathrinand non-clathrin-mediated pathways, vesicle escape and nuclear delivery appear to be supported by a clathrin-mediated pathway. As our previous efforts have focused on utilizing
Introduction
The proteins that comprise the icosahedral-shaped adenovirus (Ad) capsid enable highly efficient viral cell entry and gene transfer. 1 One of the capsid proteins, the penton base, is a homopentameric protein unit located at each vertex of the Ad icosahedron. The penton base enables cell entry by binding cellular a v b 3 -or a v b 5 -integrins through an Arg-Gly-Asp (RGD) sequence found on the Ad penton base, 2, 3 and triggering receptor-mediated endocytosis of the whole virus. Another capsid protein, the fiber, initiates infection by binding the coxsackievirus adenovirus receptor, an event that precedes the penton-integrin interaction. 4 The fiber is non-covalently bound to the penton base through its amino (N)-terminal 'tail' domain, 5 and can self-assemble with free penton base proteins in vitro to form penton base-fiber 'capsomers'. [5] [6] [7] [8] The interactions of Ad capsid proteins with certain cellular factors during the early stages of viral infection induce a cooperativity between virus and cell that enables viral uptake using normal cellular processes. 1 The accumulation of integrins at sites of focal adhesion where the extracellular matrix makes contacts with the cell membrane is replaced by the induction of integrin clustering by the Ad penton base upon cell binding. 9 The downstream intracellular signaling, enhanced by receptor clustering, induces the recruitment of clathrin and associated proteins at coated pits formed at the local sites of Ad particle cell surface binding. 10 Also induced is the polymerization of cytoskeletal proteins mediating the invagination and pinching-off of coated vesicles containing Ad particles. 11 The Ad cell entry route is consistent with a classical clathrin-mediated endocytic pathway that typically leads to vesicle uncoating and acidification, then finally fusion of endosomal vesicles with lysosomes. 1 Some studies suggest that acidification of such vesicles triggers conformational changes in the capsid of Group C Ad, which includes Ad2 and Ad5, resulting in lysis of the endosomal membrane and allowing early escape of the virus to the cytosol. 12 Cytoskeletal motors used typically to transport vesiculated cargo along polymerized microtubules are appropriated for mobilizing the viral capsid to the nuclear periphery, where the viral genome is eventually transferred across the nuclear membrane through nuclear pores. 13, 14 Escape of Ad from endosomes enables evasion of lysosomal degradation, and has been attributed to the penton base. 15 Based on the cell entry and penetration features of the penton base, we have produced a non-viral gene transfer complex, 3PO, which has incorporated recombinant Ad5 penton base proteins (PB). 16 Similar non-viral vectors have been derived from the penton base proteins of Ad3 17 and Ad7 18 capsids. In all of these studies, gene transfer relied on integrin binding and endocytosis, and the final gene expression of the DNA cargo defined the efficiency of delivery from the cell surface to the nucleus. We have found that whereas nearly 100% of exposed cells were bound by PB, gene transfer and expression by 3PO was detectable in p10% of treated cells. 16 This observation led us to examine whether intracellular trafficking barriers inhibit efficient gene transfer, and gave us pause to re-evaluate the use of recombinant penton base proteins as cell entry and intracellular trafficking vehicles.
In previous studies, we have reported that PB undergoes transit from the plasma membrane toward the nuclear periphery after temperature-dependent uptake. 1, 8 In the present study, we have examined PB intracellular trafficking more extensively using confocal fluorescence microscopy and biochemical methods on fixed and live HeLa cells, and observe the trafficking patterns over the time course of cell entry. Whereas some of our findings echo those observed on the intracellular trafficking of whole Ad, we also observed some new, previously not reported trafficking patterns, which suggest that PB enters cells through multiple trafficking pathways. Here, we have found that the majority of internalized PB accumulate around the nucleus by 1 h after cell entry and that a subpopulation of internalized PB also accumulate in the nucleus. Nuclear targeting is partially dependent on intact microtubules and dynein, and during cell entry, PB partially colocalizes with internalized integrins. Similar to whole Ad, PB largely avoids lysosomes and facilitates the early release of vesicle contents from endosomes. Interestingly, we also observed partial colocalization of PB with caveolin and an increased overlap with Golgi markers over time, suggesting that PB enters cells through clathrin-and non-clathrin-mediated pathways.
Results

PB undergoes perinuclear and nuclear accumulation
Recombinant PB was prepared as a histidine-tagged fusion protein, with the tag left intact in these studies, and has been shown by non-denaturing electrophoretic methods in our earlier studies to migrate at a molecular weight consistent with pentamers. 16 To first examine the overall long-term survival and detection of PB after cell uptake, we incubated PB with HeLa cells at 41C to promote receptor binding but not internalization, then incubated the cells at 371C to induce endocytosis before fixing the cells at specific time points up to 24 h after warming. Using immunofluorescent labeling and confocal microscopy, we observed that PB immunofluorescence was sustained at relatively high levels up to 4 h after cell entry, whereas by 24 h, substantial PB fluorescence was detectable in only a few cells (Figure 1) .
Upon closer examination, we observed that at 41C (or 0 min of warming) PB accumulated on the cell membrane, then clustered into foci at the cell membrane by 5 min (Figure 2a) . By 15 min, PB immunofluorescence spread into the cytoplasm, and away from the cell membrane, in localized focal accumulations, then appeared to mostly surround the nucleus by 45 min (Figure 2a) . By 30 min, nearly 50% of internalized PB accumulated within the perinuclear region (Figure 2b ). Of the cells in which PB persisted up to 24 h after cell entry, PB remained mostly in cytoplasmic and perinuclear regions (Figure 2b ). Trypsinization and Western blotting of the treated cells at early time points confirmed that the observed pattern of cell entry reflected internalized as opposed to cell surface PB, as an increasing amount of PB became trypsin resistant over time (Figure 2c) .
Upon closer examination, we noticed that a subpopulation of internalized PB appeared to accumulate in the nucleus over time (Figure 3a) . To confirm this observation, we examined stacked images captured along the z axis of the microscopic viewing plane and, using confocal analysis software, highlighted only those PB particles that coincided with the nucleus. A side (x-z) profile of the cell shows that PB particles were inside the nucleus beginning at 30 min after uptake (Figure 3b ). Nuclear PB continued to accumulate, reaching nearly 10-15% of the total internalized population by 2 h after uptake, then decreasing dramatically by 24 h after uptake ( Figure 3c) .
As a further confirmation of these findings, we fractionated cells at 2 h after uptake and examined the distribution of intracellular PB. Our findings show that between 20 and 25% of internalized PB is found in the nuclear fraction, and that a similar percentage associates with membranes ( Figure 3d ). Importantly, very little PB is apparently free in the cytoplasm, but rather the majority of cytoplasmic PB is associated with the cytoskeleton (Figure 3d ).
Intact microtubules and dynein are required for nuclear targeting
As cytoskeletal elements, particularly microtubules, are known to act as scaffolds for trafficking of pathogens, including Ad, to the nucleus, 13, 14 we examined whether
Penton base trafficking A Rentsendorj et al microtubules contribute to nuclear targeting of PB. To do so, we performed binding and uptake of PB in the presence of the microtubule depolymerizing agent, nocodazole (Noc). In the absence of Noc, microtubules remained intact and web-like, and PB particles were located in the cytoplasm, especially near the nuclear periphery, and appeared to associate with microtubule threads (Figure 4a ). In contrast, Noc produced diffuse a-tubulin staining, indicative of microtubule depolymerization. Importantly, intracellular PB localized near the cell periphery in these cells, even after 45 min at 371C (Figure 4a ), suggesting that although microtubules are not required for initial cell entry, they are important for intracellular trafficking toward the nucleus once PB is internalized. Nocodazole appeared to prevent B60% of PB from translocating to the perinuclear region ( Figure 4b ). The partial requirement of intact microtubules for nuclear targeting might suggest that the microtubule minus-end-directed cytoplasmic dynein motor contributes to PB transport along the microtubule. 13 Dynein typically mediates the transport of vesiculated cargo along microtubule tracks from the cell periphery to various subcellular locations, including lysosomes and the nucleus. [19] [20] [21] Dynein has been implicated more recently in the transport of naked viral capsids from endosomes to the nuclear periphery. 13 To determine whether dynein is required for PB translocation, we transfected HeLa cells with a plasmid overexpressing the p50/dynamitin (p50/dyn) subunit of dynein, which results in disruption of the dynein motor complex. 22 Cells were co-transfected with a plasmid expressing green fluorescent protein (GFP) to mark transfected cells. Whereas both untransfected and mock-transfected (i.e. GFP-negative) cells displayed perinuclear PB foci, p50/dyn produced scattered PB foci throughout the cytoplasm (Figure 4c and e), reducing perinuclear localization of PB by B50% (Figure 4d ). Importantly, even within the same wells, cells receiving the plasmids (i.e. GFP-positive cells) displayed scattered PB fluorescence, whereas the PB in GFP-negative cells were mostly localized near the nuclear periphery (Figure 4e ). These findings suggest that B50% of PB translocating to the nuclear periphery require intact dynein for intracellular trafficking.
Molecular specificity of recombinant penton base uptake
Microtubules mediate vesicular traffic arising from several different cell entry pathways, including clathrinand caveolin-associated routes. As previous studies have established that Ad5 enters cells through integrin endocytosis, which has been associated with a clathrinmediated route, 23, 24 we wanted to verify whether PB was entering cells in a similar fashion. To do so, we first examined whether PB entered cells via integrin interaction by testing the cell binding activity of PB carrying a mutation in the integrin binding site.
We produced the binding-defective mutant, PBrgd, which carries an R340E mutation that is reported elsewhere to ablate binding to a v -integrins. 3, 16 Confocal microscopy of immunostained HeLa cells after incubation with either PB or PBrgd showed that equivalent amounts of PBrgd did not bind the cells at 41C whereas PB did (Figure 5a ), and indicated that the R340E mutation reduced both cell binding and subsequent uptake by nearly 80% (Figure 5b) . Importantly, the R340E mutation did not destroy immunorecognition of PBrgd ( Figure 5c ).
As an additional confirmation of cell binding, we incubated HeLa cells in suspension at 41C with either PB or PBrgd, and then examined lysates of pelleted cells for the presence of each protein by Western blotting. Whereas the cell pellets precipitated PB, little to no PBrgd bound to the cells (Figure 5d ), thus confirming our previous results. To further verify whether PB enters cells via a v -integrins, we co-immunostained HeLa cells for PB and a v -integrin at specific time points of PB uptake. At 0 min of uptake, cell surface integrin and PB coincided, although a substantial level of cytoplasmic integrin was detectable, and by 5 min, both PB and integrin fluorescence intensities increased, suggesting that both PB and integrins clustered at the cell surface (Figure 6a ). Interestingly, PB and integrins did not completely overlap, but rather PB appeared to slightly precede the integrin fluorescence at 5 min, which might suggest that as PB internalizes, integrins continue to cluster at the cell surface. At 45 min, both PB and integrins were found nearly exclusively in the cytoplasm, in a perinuclear pattern (Figure 6a) , with the majority of a v -integrins accumulating around the nucleus (Figure 6b ).
Whereas PB induced massive internalization of integrins, the partial overlap of PB with integrins suggests that a portion of PB enters cells through a v -integrinindependent pathways. To determine the extent to which PB and integrin patterns coincide, we measured the overlap between PB and integrin fluorescence at each time point. At the early stages of PB uptake (0-15 min), about 20% or less of internalized PB overlapped with integrins, whereas at later stages (30 min to 4 h), nearly 50% of PB coincided with integrins ( Figure 6c ).
One explanation for the partial, but temporally increasing, overlap of PB and integrin fluorescence from 0 to 30 min is that integrins not bound by PB merge with intracellular compartments containing PB-bound integrins. As the merging of separate vesicle populations should increase the size of the resulting merged vesicle, we measured the average size (by area) of overlapping PB and integrin foci. The average focal size (Figure 6d ), suggesting that local intracellular compartments containing both integrins and PB increase nearly three times in size during intracellular trafficking. Surprisingly, very little of internalized integrins overlapped with the early endosomal marker, EEA1, during PB-induced endocytosis (Figure 6b ), suggesting that, whereas HeLa cell entry of PB requires binding to a v -integrins, the internalization pathway stimulated by PB may differ from that utilized by whole Ad5. To investigate this possibility further, we utilized several markers of various internalization pathways, as described below.
PB avoids lysosomes and coincides with alternative pathway markers
Endocytic vesicles emerging from clathrin-mediated endocytosis eventually merge with lysosomes to degrade the payload. In contrast, cell entry via non-coated vesicles (such as caveolar endocytosis) avoid lysosomes. 25 To determine whether PB is transported to lysosomes after uptake, we examined the subcellular location of PB in relation to the lysosomal marker, LAMP-1. At 41C, PB is located at the cell periphery whereas LAMP-1 is found internally, and at 45 min, PB and LAMP-1 are still located in separate, non-overlapping foci (not shown). By 2 h, PB remained largely distinct from LAMP-1 (Figure 7a ). Up to 4 h of PB Penton base trafficking A Rentsendorj et al uptake, we measured little to no overlap of PB and LAMP-1 (Figure 7b ), suggesting that the preponderance of PB does not translocate to lysosomes after uptake.
To determine whether PB is associated with coated vesicles during uptake, we co-immunostained PB-treated cells for PB and clathrin. Interestingly, we found little overlap of PB with clathrin at a very early (i.e. 5 min) stage of uptake (at which time we would expect to see colocalization with coated pits and vesicles), but a timedependent increase in overlap at a later (i.e. 30 min) stage of uptake (Figure 7c and d). Arrival at organelles associated with vesicle budding, such as the trans-Golgi network (TGN), could explain this pattern. To investigate this possibility, we co-stained for g-adaptin (Figure 7a ), which is a subunit of the clathrin-associated protein (AP-1) complex that, in turn, is associated with vesicle budding at the TGN. 26, 27 We observed a steadily increasing percentage of total PB overlapping with g-adaptin for up to 2 h of uptake, after which the percentage of overlapping PB decreased to nearly negligible levels (Figure 7b ).
Taken together with the earlier findings, it is possible that a non-classical pathway contributes to PB trafficking, mediating arrival at clathrin-and g-adaptin-positive structures, such as the Golgi, after uptake. One pathway that supports this trafficking pattern is caveolae- Figure 4 Microtubule and dynein requirement for nuclear targeting. HeLa cells were treated with nocodazole (Noc) for 1 h at 371C before incubation with recombinant Ad5 penton base proteins (PB) for 2 h at 41C followed by 371C for 45 min, as described in Materials and methods. (a) Immunostaining and confocal microscopy of PB trafficking without (left panel) and with (right panel) the microtubule disruption agent, Noc. Microtubules were identified by immunostaining using an anti-a-tubulin antibody, as described in Materials and methods. (b) Quantification of the effect of Noc on intracellular PB traffic. PB fluorescence was selected by measuring the pixel count from levels 100 to 255 in the green channel. Perinuclear PB were measured by selecting the inner 1/3 of the cell cytoplasm, delineated by an oval around the nucleus in (a), and recording the PB fluorescence within the selected area. The results were plotted in (b) as a percentage of total intracellular PB (Po0.0001). Red, a-tubulin; green, PB; n, nucleus. 
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A Rentsendorj et al mediated cell entry, which is known to mediate internalization and retrograde trafficking of cholera toxin 28 and SV40, 29, 30 and facilitate toxin arrival to the Golgi. We found that indeed PB partially overlaps with the caveolae marker, caveolin-1, during uptake (Figure 7e and f). Consistent with previous studies on caveolae formation, 31 this marker was found mostly at the cortical surface of the cell (Figure 7e , right panels) and persisted for prolonged time points (i.e. 90 min and longer) after uptake (Figure 7f ).
Effect of traffic inhibitors
Several types of drugs inhibit pathways mediated by either clathrin or caveolae, or both. The cholesteroldepleting drug, methyl-b-cyclodextrin (MBCD), is known to inhibit both clathrin-and caveolae-mediated routes. 32, 33 Perinuclear accumulation was dramatically inhibited by nearly 90% and nuclear accumulation was nearly completely abolished compared to PB uptake without MBCD (Figure 8 ). To better delineate uptake routes, we treated cells with the protein tyrosine kinase inhibitor, genistein, which prevents caveolae-mediated uptake of SV40 34 and macromolecules. 35 Genistein at 0.1 mM affected PB uptake and perinuclear accumulation a little, whereas nuclear accumulation was inhibited by nearly 50% compared to uptake without the drug ( Figure  8) . A possible indirect route to the nucleus via caveolae could be the retrograde trafficking pathway of toxins and pathogens, which arrive at the Golgi en route to the endoplasmic reticulum (ER), from which release into the cytoplasm is possible. 36, 37 Brefeldin A (BFA), which inhibits the Golgi to ER pathway, prevents retrograde trafficking of SV40 and cholera toxin, 30, 38 but here had little effect on perinuclear and nuclear accumulation of PB ( Figure 8 ). To further examine uptake routes, we treated cells with the cholesterol-chelating drug, nystatin, which interferes with lipid raft-mediated endocytosis 39 but not clathrin coat assembly when used at low concentrations (20-60 mg/ml). 32, 33, 40 Here, however, we observe that at 25 mg/ml, nystatin had little effect on perinuclear and nuclear accumulation of PB (Figure 8 ). Taken together, these findings suggest that nuclear targeting is supported largely by a clathrin-mediated pathway.
Contribution to endosomolysis
The arrival of a certain percentage of internalized PB into the nucleus suggests that at least a portion of internalized PB somehow escape endosomes. To determine whether PB lyses the endosomal vesicle after uptake, we examined the fate of 10 000 molecular weight (mw) FITC-dextran during co-uptake with PB in HeLa cells. FITC-dextran serves as a fluid-phase marker that, alone, is unable to penetrate the cell membrane. FITC-dextran alone undergoes low-level, pinocytic-like cell entry, but remains in small vesicles at 45 min of uptake (Figure 9a , left panel). In contrast, PB not only appears to stimulate uptake of FITC-dextran but also produces a diffuse fluorescence throughout the cytoplasm (Figure 9a, right  panel) . The escape of FITC-dextran from vesicles by endosomolysis is marked by a shift from bright, punctate fluorescence to dull, diffuse fluorescence in the cytoplasm owing to marker dispersal, which can be quantified by scoring cellular fluorescence. We compared fluorescence stimulation by PB with Ad5 used at an MOI Figure 9a . Interestingly, we found that the addition of WTF to PB seemed to prolong the fluorescence retention of FITC-dextran ( Figure 9b ). As vesicular FITC-dextran produced a higher fluorescence intensity than dispersed FITC-dextran, we could indirectly quantify FITC-dextran release by measuring cellular fluorescence intensity by fluorimetry. Untreated cells accumulated fluorescence intensity over time, whereas cells treated with virus or capsid proteins had reduced fluorescence intensity levels over time. As determined by subtracting the fluorescence intensity from capsid protein (or virus)-treated from untreated cells, we found that both PB+WTF and Ad5 released between 30 and 55% of FITC-dextran from bright foci, whereas PB produced more variable results, releasing between 5 and 45% of FITC-dextran (Figure 9c ). It is possible that the above results could reflect the return of FITC-dextran to the cell surface from recycling endosomes; thus, we wanted to further test for vesicle release by utilizing a molecule that required cytoplasmic delivery to be active. We therefore examined whether the penton base could support the delivery of an siRNA molecule, as RNA interference (RNAi) of a marker gene would indicate that the siRNA molecule can access the cytosol. We mixed PB modified to transport nucleic acids (PBK10) 16 with an siRNA molecule targeted against transcripts encoding enhanced green fluorescent protein (EGFP). Importantly, the plasmid encoding EGFP was transfected into the cells 24 h after the PBK10-siRNA complex. The siRNA delivered by PBK10 induced nearly 50-60% knockdown of EGFP, whereas siRNA alone (without PBK10) had no effect (Figure 9d ). Delivery of a Cy3-labeled oligonucleotide separately confirmed that the penton base protein could internalize small nucleic acids whereas the oligonucleotide alone was unable to enter cells (Figure 9e It is possible that the polylysine of PBK10 could contribute to cell entry of siRNA or oligonucleotides via binding to cell surface anions, such as sulfated proteoglycans, and thus affect the cell uptake route and fate of the nucleic acid molecule. Therefore, we confirmed whether siRNA could be delivered into the cells by couptake with PB. In these experiments, we used a synthetic anti-GFP siRNA pre-mixed with PB, PBK10 or Lipofectamine 2000t. Whereas siRNA alone had no effect on GFP expression, siRNA added with PB, PBK10 or Lipofectamine 2000t mediated up to 20-30% GFP knockdown by 24 h after siRNA delivery (Figure 9f ). Whereas gene knockdown was not as extensive as the previous experiment (Figure 9d ), which mainly differed by the type of siRNA molecule used, reduction of GFP expression significantly differed from untreated cells or cells receiving siRNA alone. As further confirmation, we also tested siRNA delivery by a PBK10 mutant (PBrgdK10), which carries a mutation in the integrin binding motif. 16 GFP expression in the cells receiving siRNA with PBrgdK10 did not significantly differ from untreated cells or cells receiving siRNA alone, suggesting that cell entry occurred via integrin binding and internalization (Figure 9f ).
Discussion
Several studies have examined the translocation pathway of whole Ad. 13, 14 Cell binding by whole Ad elicits virusreceptor clustering at the cell surface, 9 followed by rapid, temperature-dependent cell entry. Escape of Group C Ad from early endosomes starts at B15 min after uptake. 23 Intracellular trafficking of the whole virus requires intact microtubules and dynein, 14 and the capsids accumulate around the perinuclear envelope, 23 largely avoiding lysosomes. Here, we have observed that in the absence of the whole virus, the penton base undergoes similar as well as anomalous cell entry and trafficking.
We have found that the majority of intracellular PB persists at high levels for at least 4 h after cell entry, then dramatically decreases by 6 h until, by 24 h, only a few cells are still marked by substantial levels of intracellular PB. This profile presents a window of survival in which penton-base-derived vectors like 3PO may need to operate for efficient delivery. Like the whole virus, we confirm here that PB undergoes temperature-dependent endocytosis via integrin binding through an RGD motif. However, a portion of internalized PB did not colocalize with a vintegrins. Recent evidence suggests that Ad5 may bind a 3 -integrins through RGD interaction; 41 thus, it is possible that PB may bind alternative receptors through its RGD motif, although this requires further investigation.
Similar to whole Ad, cytosolic transit of PB resulted in perinuclear accumulation, and nuclear targeting was impeded by microtubule and dynein disruption. Whereas most vesiculated cargo undergo microtubuleand dynein-dependent translocation, identification of a subpopulation of PB coinciding with the nucleus suggests that a certain percentage can escape the endosomal vesicle. Here, we have found that about Penton base trafficking A Rentsendorj et al 25% of PB partitions with the nuclear fraction, echoing similar findings reported previously for soluble Ad2 penton base. 42 Using high-resolution confocal microscopy and analysis, we determined that 10-15% of PB localized within the nucleus. This slight discrepancy from the cell fractionation results may be explained by the possibility that fractionation techniques may isolate nuclear-bound as well as intranuclear proteins. That only 10-15% of PB enter the nucleus (and thus presumably escape vesicles) may partially explain the relatively low transduction efficiency of 3PO 16 compared to whole Ad. Interestingly, our cell fractionation indicated that there was little free PB in the cytosol whereas the majority of cytosolic PB associated with the cytoskeleton. Indirect evidence suggests that naked Ad particles interact with dynein to translocate toward the nucleus. 13, 14 Whether or not PB directly interacts with cytoskeletal elements or dynein motors remains to be seen. Overlapping fluorophores were measured by selecting levels 100-255 in the red+green multiplied channels, selecting only coincident red and green labels, and recording the total pixel count of these foci. The results were plotted as a percentage of total PB foci. Green, PB; blue, nucleus; red, indicated marker. Bar, B16 mm.
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The majority of internalized PB avoided lysosomes, suggesting that either PB escapes endosomes after clathrin-mediated cell entry or PB traffics through an alternative pathway, such as caveolar endocytosis, which also avoids endosomes. 25 Interestingly, whereas a v -integrins appeared to contribute greatly to PB cell binding and entry, substantial early passage through endocytic markers, clathrin or EEA-1, was not detected. Moreover, overlap with the TGN marker, g-adaptin, was observed, as was partial colocalization with caveolin-1. Overlap with clathrin at later, but not earlier, stages of cell entry may further indicate that PB partially translocates to the TGN, from which clathrin-coated traffic emerges. It is possible that a certain population of PB arrives at the TGN in a similar fashion to the retrograde trafficking of adeno-associated virus capsids and toxins after endocytosis. 43, 44 While this pathway can lead to ER delivery, the inability of BFA to modulate perinuclear and nuclear accumulation suggests that the Golgi to ER retrieval pathway does not contribute to PB trafficking.
The vesicles pinched off from caveolae, known as 'cavicles', require intact microtubules to traffic away from the plasma membrane. 31 Interestingly, caveolae persist at the cell surface for prolonged periods of time, 31 in support of our finding that partial colocalization of PB with caveolin-1 was observed up to 3 h after cell binding. The cholesterol chelating drug, nystatin, can inhibit caveolar or lipid raft endocytosis, but did not significantly modulate nuclear targeting. On the other hand, MBCD, which inhibits both clathrin-and caveolarmediated endocytosis, dramatically inhibited both perinuclear and nuclear accumulation. Taken together, these findings suggest that although PB may enter cells through both clathrin-and caveolar-mediated pathways, nuclear delivery (and hence endosome escape) is supported mainly by clathrin-mediated endocytosis.
The protein tyrosine kinase inhibitor, genistein, prevents caveolar endocytosis of SV40 34 and macromolecules, 35 but did not affect perinuclear accumulation of PB although nuclear uptake was inhibited nearly 50%. It is possible that signal modulation through phosphorylation is a partial requirement for nuclear entry. Such signaling may be transmitted from integrins and can originate from caveolae-or clathrin-coated pits. For example, it is well known that caveolae are sites of signal transduction, 45 and the integrin a subunit contains a caveolin-1 binding domain. 46 Moreover, a2-integrins mediate echovirus internalization via caveolae, 47 and caveolin-1 can modulate signaling from integrin-linked kinase 1. 48 On the other hand, the polyoma JC virus induces genistein-sensitive signaling required for clathrin-dependent cell entry. 49 Based on our studies here, it is intriguing to speculate that signaling induced by caveolae-bound PB facilitates escape of PB from endosomal vesicles arising from the clathrin-dependent pathway, thus enabling entry into the nucleus. Alternatively, such signaling may arise from clathrin-coated pits as well. A scenario of signal-dependent vesicle release has been presented before by Meier et al., 50 in which signaling from cell surface-bound Ad induces macropinocytosis and vesicle leakage.
Similar to the whole virus, PB mediated the shift in FITC-dextran labeling from localized intracellular accumulations to dispersed signals in the cytoplasm after 15 min of uptake (the stage at which the virus is expected to lyse early endosomes). The findings here suggest that PB mediates the early leakage of the endosomal membrane, enabling the escape and dispersal of FITCdextran, as well as a Cy3-labeled oligonucleotide, into the cytoplasm. Interestingly, PB+WTF together retained FITC-dextran in localized accumulations (not shown) longer than Ad5 or PB alone, facilitating dispersal of the signal after 30 min of uptake. The influence of the fiber on the timing of vesicular escape is, perhaps, not surprising, as previous studies have suggested that the fiber determines whether an Ad serotype escapes to the cytoplasm at early or late stages of endosome maturation. 51, 52 Recent findings on the ability of soluble fiber to induce endocytic uptake present the further possibility that the fiber stimulates an additional pathway that perhaps contributes to delayed release of vesicle contents into the cytoplasm. 8 As a test of cytosolic penetration by the penton base, we show that either PB or PBK10 facilitate RNAi of a GFP marker gene by delivering a specific siRNA molecule. In some cases, GFP expression was reduced by 50-60% (Figure 9d ), whereas in other experiments GFP expression was reduced by 20-30% (Figure 9f) . This difference may correlate with whether the siRNA was T7 transcribed (Figure 9d ) or synthetic (Figure 9f) . Previous studies have shown that T7 transcribed, but not synthetic, siRNA molecules can induce a cytokine-mediated cytotoxic response, 53 which might contribute to the substantial knockdown observed here. In either case, we find here that by 24 h after siRNA delivery, both PB and PBK10 induce similar levels of knockdown as Lipofectamine 2000t, and all three conditions produced significantly reduced GFP expression compared to untreated GFP-expressing cells or siRNA alone.
From these studies, we are unable to determine what percentage of internalized PB actually induce leakage. A recent report that Ad protein VI may instead be responsible for vesicle lysis would suggest that the Figure 8 Effect of trafficking inhibitors. Cells were pre-incubated with the indicated inhibitors before incubation with recombinant Ad5 penton base proteins (PB) at 41C for 2 h followed by incubation at 371C for 45 min, as described in Materials and methods. Perinuclear and nuclear accumulation of PB was measured and plotted as described previously in the legends to Figures 2 and 3 , respectively. Dashed line indicates 'zero' on the y axis. The significance of each drug effect was tested in comparison to control (mock) treated cells. *Po0.0001; **Po0.003; ***Po0.0005.
Penton base trafficking A Rentsendorj et al penton base merely mediates internalization of the virus but not endosome escape. 54 However, the nuclear accumulation of the penton base reported here and elsewhere 42 would suggest that at least a certain subpopulation of free penton base proteins are somehow able to penetrate the endosomal membrane. The ability of the penton base to facilitate RNAi further supports an endosomolytic capacity, and introduces an interesting alternative utilization of this molecule to plasmid delivery.
Taken together, our findings might suggest that cell entry through multiple pathways may impede highefficiency gene transfer, as partial entry into caveolae may present a dead end. On the other hand, it appears that the level of cytosolic penetration by the penton base is sufficient to facilitate substantial RNAi of a marker gene. Along these lines, it would appear that problems with penton base-mediated gene transfer may not be due to penton base trafficking barriers but rather lie with the plasmid itself, and, although not addressed here, could include difficulty with sufficient DNA compaction, inability for sufficient plasmid trafficking through the cytosol 55 and cytosolic cleavage of plasmid DNA. 56 As we continue our efforts to better understand the translocation pathways of the Ad capsid proteins, we expect to utilize these findings to make improvements in 
Materials and methods
Materials
HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and penicillin/streptomycin at 371C in 5% CO 2 . The pCMVH50myc plasmid construct, encoding p50/dynamitin (p50/dyn), was obtained from Dr Janis Burkhardt ( 
DNA constructs
The sequences encoding PB, PBrgd and GFP-PB were inserted into the pRSET-A bacterial expression plasmid (Invitrogen, Carlsbad, CA, USA). Constructs encoding PB and GFP-PB were assembled as described previously. 16 The construct encoding PBrgd was assembled by polymerase chain reaction amplification of the pRSET-PBrgdK10 template 16 using 5 0 and 3 0 oligonucleotide primers encompassing the 5 0 and 3 0 ends of the wildtype Ad5 penton base coding sequence.
Protein production and purification
Recombinant PB, PBrgd and GFP-PB proteins were expressed in Escherichia coli as histidine-tagged fusion proteins, and purified by metal chelate affinity chromatography following previously described procedures. 16 The histidine tag was not removed from recombinant proteins.
Immunoblotting
Purified PB and PBrgd (5 mg each) were resolved by SDS-denaturing polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were electrically transferred onto nitrocellulose using 39 mM glycine, 48 mM Tris-HCl, 0.0375% SDS and 20% methanol in a BioRad semi-dry transfer cell set at constant voltage (15 V) for 30 min. Blots were incubated in blocking buffer (3% milk in TBS) overnight, then probed with Ad5 antibody (1:5000) in blocking buffer, followed by thorough washing in TBST-T and probing with HRP-GAR secondary antibody (Sigma-Aldrich Corp., St Louis, MO, USA) (1:10 000), then processed for chemiluminescence using ECL Detection Reagents (Amersham Pharmacia, Piscataway, NJ, USA) following the manufacturer's protocol, and exposed to film (Hyperfilm ECL; Amersham Pharmacia, Piscataway, NJ, USA).
To detect internalized proteins, HeLa cells grown to subconfluency were detached from the substratum with 2 mM EDTA, washed and resuspended in Buffer A+3% BSA in 0.7 ml aliquots at 4 Â 10 5 cells/tube. Cells were incubated for 2 h at 41C with 20 mg of PB per tube, then individual tubes warmed to 371C for the indicated lengths of time. At each time point, cells were pelleted, resuspended in 2.5 mg/ml trypsin/2 mM EDTA and incubated at 371C for 1 min. Complete media (1 ml) were then added to each tube and the cells were re-pelleted, washed and lysed in 50 ml SDS-PAGE sample buffer. One tube ('Bound only') remained at 41C and received no trypsin treatment. Another tube ('Untreated') received no PB. Lysates were resolved by SDS-PAGE, transferred to blotting membranes and immunoblotted as described earlier.
For the cell fractionation, 2.5 Â 10 6 HeLa cells were lifted using 2 mM EDTA for 1.5 h, then washed and suspended in 0.7 ml Buffer A. Control cells received no protein, whereas 200 mg penton base protein was added to the PB sample. Samples were incubated at 41C for 2 h on end-over-end shaker and then at 371C for 2 h on rocker. Cell fractionation procedure followed the manufacturer's recommended protocol (Qiagen, Valencia, CA, USA). Cell fractions were run on 10% SDS-PAGE gel and probed with pre-adsorbed Ad5 Ab. Lanes contained 20 mg each of cytosolic and membrane fractions, 16 mg of nuclear fractions and 11 mg of cytoskeletal fractions.
To detect the binding specificity of PB and PBrgd, HeLa cells were lifted with 2 mM EDTA/PBS at 371C with agitation for about 30 min. Cells were then pelleted, washed and resuspended with Buffer A, then divided into three tubes at 2 Â 10 6 cells each. One tube received 20 mg PB, another received 20 mg PBrgd and the third tube remained untreated. Cells were incubated for 2 h on ice to promote receptor binding but not internalization, washed three times in PBS, pelleted and resuspended in SDS-PAGE sample buffer. Samples were resolved under denaturing, reducing conditions and immunoblotted as described earlier, using an HRP-conjugated anti-His-tag antibody at 1:700 dilution.
Penton base uptake assays
For penton base uptake assays, HeLa cells were plated on coverslips in a six-well dish at 2 Â 10 5 cells/well and To study the time course of uptake, cells were washed twice with cold PBS, then 0.7 ml of Buffer A with 20 mg PB was added to each well. Dishes were incubated for 1 h on ice to promote receptor binding but not internalization, then cells were washed with cold PBS to remove free protein. Aspirated wells then received pre-warmed complete media, and dishes were incubated at 371C at 5% CO 2 . At the indicated time points, individual coverslips were removed, washed three times with PBS/1% MgCl 2 and processed for immunostaining as described later.
To study the specificity of binding and uptake, separate wells were incubated with 20 mg of (a) PB or (b) PBrgd in 0.7 ml Buffer A for 2 h at 41C. Individual wells were transferred to 371C for 5 min to promote cell entry, then processed for immunostaining as described later.
To study the role of microtubules in trafficking, cells were treated with 33 mM Noc in 0.7 ml Buffer A for 1 h at 371C following an initial 5 min incubation on ice. Then, 20 mg PB was added to the medium and incubated with the cells at 41C for 2 h. Cells were transferred to 371C for 45 min and processed for immunostaining as described later. Nocodazole remained present in all incubations before and during the addition of PB to the cells.
To determine whether PB proteins overlap with lysosomes or clathrin coat proteins, separate wells were treated with 20 mg PB in 0.7 ml Buffer A for 2 h at 41C, then warmed to 371C for 45 min and processed for immunostaining using antibodies against PB and LAMP-1 or g-adaptin as described later.
To study the effect of dynein disruption, cells were cotransfected with plasmids (0.5 and 1 mg each) encoding GFP and p50/dyn, respectively, using Lipofectamine 2000 following the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA). At 24 h post-transfection, PB (20 mg/well) was added to the cells at 41C to promote cell binding but not internalization, then cells were warmed to 371C for 45 min to promote uptake, following the details described earlier for studying the time course of uptake. Cells were fixed and processed for immunostaining as described below, using antibodies against PB and a Texas Red-GAR secondary antibody to distinguish PB in GFP-positive cells.
To study the effect of trafficking pathway inhibitors, HeLa cells were pre-incubated for 30-60 min at 371C in complete media containing 100 mM genistein, 2.5 mg/ml BFA or 25 mg/ml nystatin. Pre-incubation with MBCD was at 1 U/ml final concentration in Buffer A (2 ml, 10 mM final) at room temperature for 1 h. All drugs were present throughout the experiments.
Cell fixation and immunostaining
After the indicated treatments described earlier, the cells on coverslips were washed 3-4 times with 1% MgCl 2 in PBS, then fixed with 4% paraformaldehyde in PBS for 15 min at room temperature. Coverslips were washed three times with PBS, then incubated with 50 mM ammonium chloride in PBS for 5 min at room temperature. Cells on coverslips were washed again three times in PBS, then incubated in 0.1% Triton X-100 in PBS for 5 min at room temperature. Cells on coverslips were washed again three times in PBS, then incubated in 1% BSA in PBS for 30 min at room temperature. Cells on coverslips were immediately incubated with primary antibodies overnight at 41C, washed three times with PBS and incubated with secondary antibodies for 1 h at room temperature in the dark. Where indicated, cells stained for actin were incubated with RP at 1:100 dilution during the secondary antibody incubation, followed by a 5 min incubation in DAPI at 300 nM final concentration. RP, DAPI and primary and secondary antibodies were all diluted in 1% BSA in PBS. After secondary antibody treatment, cells on coverslips were washed three times with PBS and mounted in Prolong Antifade mounting medium (Molecular Probes, Eugene, OR, USA). For detecting PB or PBrgd, the Ad5 antibody was used at 1:500 dilution, and a fluorophore-conjugated goat antirabbit (either FITC-conjugated at 1:300 dilution or Texas Red-conjugated at 1:1000 dilution) was used for fluorescence detection. The anti-a v -integrin antibody was used at 1:1000 dilution, and detected using TRITC-GAM at 1:100 dilution. The anti-a-tubulin antibody was used at 1:300 dilution for detecting microtubules. The anti-LAMP-1 antibody was used at 1:1000 dilution. The anti-g-adaptin antibody was used at 1:100 dilution.
Confocal fluorescence microscopy
Confocal micrographs were obtained using either a Nikon PCM Confocal System equipped with argon ion and green HeNe lasers attached to a Nikon TE300 Quantum inverted microscope, or a Leica confocal microscope TCS SP2 with AOBS equipped with a 405 nm violet diode UV laser, 488 nm argon laser and 543 nm (green), 594 nm (orange) and 633 nm (red) HeNe lasers, and using an HCX PL APO Â 63 1.4 NA oil objective (Leica Microsystems, Heidelberg, Mannheim, Germany). Images were compiled and analyzed in Adobe Photoshop (Adobe Systems Inc., Mountain View, CA, USA).
FITC-dextran uptake
To observe FITC-dextran uptake by confocal microscopy, HeLa cells were plated on glass coverslips at 1 Â 10 5 cells/well in a 24-well dish. At 48 h after plating, cells were serum-starved for 4 h in DMEM-BSA (DMEM, 0.2% BSA, 0.02 M HEPES), then incubated with Ad5-GFP (at MOI 2), PB (5 mg/well) or PB+wild-type fiber (WTF) at 5 mg each, on ice for 1 h in Buffer A. Cells were then briefly rinsed with cold DMEM and incubated with FITC-dextran (1 mg/ml) in DMEM-BSA for 15 min at 371C, 5% CO 2 . Media were then replaced with DMEM-BSA and further incubated at 371C. Samples were collected at the indicated time points of incubation, washed with PBS, then visualized by fluorescence confocal microscopy using a live cell chamber.
To measure intracellular FITC-dextran fluorescence, HeLa cells were plated in a 96-well plate at 1 Â 10 4 cells/ well and grown for 2 days. On the day of treatment, cells were serum starved as described earlier, then incubated with Ad5-GFP (at MOI 2) PB (1.2 mg/well) or PB+WTF at 1.2 mg each, on ice for 1 h in Buffer A. Cells were then briefly rinsed with cold DMEM and incubated with FITC-dextran (1 mg/ml) in DMEM-BSA for 15 min at 371C, 5% CO 2 . Media were then replaced with DMEM-BSA and further incubated at 371C. At each time point, Oligonucleotide and siRNA delivery
For the experiments depicted by Figure 9d and e, HeLa cells were plated in 12-well dishes at B1.5 Â 10 5 cells/ well and grown for 2 days before treatment. On the day of treatment, 10 mg of PBK10 was incubated with 1 ml of either (1) 40 mM T7 transcribed anti-GFP siRNA 53 or (2) 100 mM Cy3-labeled 30-mer oligonucleotide, at room temperature for 30 min in a 100 ml final volume of DMEM, then added to cells in Buffer A and incubated for 4 h at 371C, after which the cells were washed with PBS and fresh media were added. Control cells received siRNA or oligonucleotide alone. At 24 h after delivery, siRNA-treated cells were transfected with 0.4 mg of a GFP-expressing plasmid (pEGFP-N1; Clontech Laboratories Inc., Palo Alto, CA, USA) using Lipofectamine 2000t (Invitrogen, Carlsbad, CA, USA) following the manufacturer's protocol. For the experiment in Figure 9f , HeLa cells plated at 2 Â 10 5 cells/well in 24-well dishes were grown for 2 days. On the day of treatment, 5-6 mg of either PB, PBK10 or PBrgdK10, or Lipofectamine 2000t (1 mg/well; Invitrogen, Carlsbad, CA, USA), was pre-incubated with 12 ml of 20 mM of synthetic anti-GFP siRNA (Green Fluorescent Protein Duplex; Dharmacon Inc., Lafayette, CO, USA) as described earlier, then mixes were added to cells in fresh complete (i.e. serumcontaining) media without antibiotics. After 24 h, the media were removed, cells were washed once with PBS and fresh media (without antibiotics) were added to the cells. The cells were then transfected with pEGFP plasmid (0.5 mg/well) as described earlier. At 24 h after plasmid transfection, the cells were washed twice with PBS, harvested and analyzed by fluorescence activated cell sorting.
